Urokinase plasminogen activator (uPA) and its type 1 inhibitor (PAI-1): Regulators of proteolysis during cancer invasion and prognostic parameters in Breast cancer-Reference-Cited by-同舟云学术

Urokinase plasminogen activator (uPA) and its type 1 inhibitor (PAI-1): Regulators of proteolysis during cancer invasion and prognostic parameters in Breast cancer

Published:1994 Issue: Volume: Page:299-309
ISSN:0927-3042
Container-title:Cancer Treatment and Research
language:
Short-container-title:

Author:

Brünner Nils,Pyke Charles,Hansen Claus Holst,Rømer John,Grøndahl-Hansen Jan,Danø Keld

Publisher

Springer US

Link

http://link.springer.com/content/pdf/10.1007/978-1-4615-2592-9_16.pdf

Reference76 articles.

1. Liotta LA, Steeg PS. 1991. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64: 327–336.

2. Dano K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Nielsen LS, Skriver L. 1985. Plasminogen activators, tissue degradation and cancer. Adv Cancer Res 44:139–266.

3. Collen D, Lijnen HR, Todd PA, Goa KL. 1989. Tissue-type plasminogen activator, a review of its pharmacology and therapeutic use as a thrombolytic agent. Drugs 38: 346–388.

4. Andreasen PA, Georg B, Lund LR, Riccio A, Stacey SN. 1990. Plasminogen activator inhibitors: hormonally regulated serpins. Mol Cell Endocrinol 68: 1–19.

5. Duffy MJ, O’Grady P, Deveney D, O’Siorain L, Fennelly JJ, Lijnen HJ. 1988. Urokinase-plasminogen activator, a marker for aggressive breast carcinomas. Cancer 62: 531–533.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Frequent loss of cystatin E/M expression implicated in the progression of prostate cancer;Oncogene;2009-06-08

2. Obesity and Breast Cancer: The Roles of Peroxisome Proliferator-Activated Receptor-γand Plasminogen Activator Inhibitor-1;PPAR Research;2009

3. Integrin α6 cleavage: A novel modification to modulate cell migration;Experimental Cell Research;2007-04

4. Transforming growth factor-β: What every pancreatic surgeon should know;Surgery;2007-01

5. Development of a Mammalian Suspension Culture for Expression of Active Recombinant Human Urokinase-type Plasminogen Activator;Cytotechnology;2005-09